Get the tools used by (smart)2 investors.

PTC Therapeutics IncNASDAQGS:PTCT

United States / Healthcare / Biotechnology

PTC Therapeutics, Inc. (PTCT)
Ionis Pharmaceuticals, Inc. (IONS)
Biogen Inc. (BIIB)
Alnylam Pharmaceuticals, Inc. (ALNY)
Santhera Pharmaceuticals Holding AG (SPHD.F)
Pfizer Inc. (PFE)
Dyadic International, Inc. (DYAI)

Performance vs Valuation Benchmarks

-19.0%681.0%1,381.0%2,731.0%-150.0x-100.0x-50.0x0.0xPTCTIONSBIIBALNYSPHD.FPFEDYAI
XAxis
Revenue Growth
YAxis
P/E Ratio
Size
Market Cap

Price Performance History

Assets: 1.14x (14.14%)
S&P 500 (SPY): 1.09x (8.89%)
Assets
S&P 500 (SPY)

Summary Table

Name
Price, Current
Fair Value (FINBOX)
Fair Value Label (FINBOX)
Fair Value (Analyst Targets)
Fair Value Label (Analyst Targets)
Label
Market Cap
Dividend Per Share
Dividend Yield
Relative Strength Index (14d)
P/E Ratio
Price / Book
Price / LTM Sales
Enterprise Value (EV)
Total Debt / Total Capital
Float Shares / Outstanding
$266.834.3%
$263.96
-1.1% Downside
Fair
$320
19.9% Upside
Fair
good
$131.320.5%
$197.77
50.6% Upside
Undervalued
$192.50
46.6% Upside
Undervalued
great
$1.401.5%
$1.43
1.9% Upside
Fair
$7.50
435.7% Upside
Bargain
fair
$28.715.3%
$24.22
-15.6% Downside
Fair
$60
109.0% Upside
Bargain
fair
$24.700.7%
$35.73
44.7% Upside
Undervalued
$30
21.5% Upside
Fair
good
$48.373.8%
$36.34
-24.9% Downside
Fair
$63
30.2% Upside
Undervalued
good
10
30
50
100
All rights reserved. Terms Of Use